SEC Comment Letter 0000000000-23-004686 to GILEAD SCIENCES, INC. (GILD) (CIK 0000882095) (GILD)

GILEAD SCIENCES, INC. (GILD) (CIK 0000882095)
Date: May 5, 2023 · CIK: 0000882095 · Accession: 0000000000-23-004686

View on Edgar

AI Filing Summary & Sentiment

Date

May 5, 2023

Author

Not clearly detected

Form

UPLOAD

Company

GILEAD SCIENCES, INC. (GILD) (CIK 0000882095)

Letter

United States securities and exchange commission logo May 5, 2023 Andrew Dickinson Chief Financial Officer Gilead Sciences, Inc. 333 Lakeside Drive Foster City, CA 94404 Re:Gilead Sciences, Inc. Form 10-K for the fiscal year ended December 31, 2022 Filed February 22, 2023 File No. 0-19731 Dear Andrew Dickinson: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

United States securities and exchange commission logo
May 5, 2023
Andrew Dickinson
Chief Financial Officer
Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404
Re:Gilead Sciences, Inc.
Form 10-K for the fiscal year ended December 31, 2022
Filed February 22, 2023
File No. 0-19731
Dear Andrew Dickinson:
            We have completed our review of your filing.  We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io